Critical Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Critical Therapeutics, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include CT2, ZYFLO, and ZYFLO CR. The owner is based in Lexington, MA.
60 Westview Street
Lexington, MA 02421
Showing of trademarks Trademarks
Trademark Classifications
Critical Therapeutics, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Critical Therapeutics, Inc. have?
Critical Therapeutics, Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 3 registered, 6 abandoned, 2 cancelled.
What trademark classes does Critical Therapeutics, Inc. file in?
Critical Therapeutics, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Critical Therapeutics, Inc.'s most well-known trademarks?
Critical Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as CT2, ZYFLO, and ZYFLO CR. These are among 3 currently registered trademarks in the portfolio.
What is Critical Therapeutics, Inc.'s trademark registration success rate?
Critical Therapeutics, Inc. has a 27% trademark registration rate, with 3 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.